Financials
- Market Capitalization 38.98 M
- Employee 36
- Founded 1997
- CEO N/A
- Website www.nephros.com
- Headquarter Delaware, United States
- FIGI BBG000NXRTF2
- Industry Medical Instruments & Supplies
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4299 | ZTEK Zentek Ltd. - common stock | 0.49 USD | +2.08% | 0.00% | +4.26% | -51.00% | 51.15 M USD | ||
| 4370 | DXR Daxor Corporation - Closed End Fund | 10.35 USD | +2.37% | -0.48% | +2.78% | -24.67% | 43.43 M USD | ||
| 4447 | MLSS Milestone Scientific, Inc. Common Stock | 0.39 USD | -2.50% | +14.71% | +11.43% | -40.00% | 34.35 M USD | ||
| 4521 | HBIO Harvard Bioscience, Inc. - Common Stock | 6.00 USD | -1.96% | -6.54% | -3.07% | +1295.35% | 27.06 M USD |
Frequently asked questions about Nephros, Inc. - Common Stock
What is the Nephros, Inc. - Common Stock stock price today?
The current price of Nephros, Inc. - Common Stock (NEPH) is 3.59. Over the past 24 hours, the stock has changed by -1.10%. Follow the NEPH chart for real-time price dynamics.
What is the stock ticker of Nephros, Inc. - Common Stock?
Nephros, Inc. - Common Stock trades under the ticker NEPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Nephros, Inc. - Common Stock stock going up?
NEPH has changed by -2.71% over the last week, +7.81% over the last month, and -5.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Nephros, Inc. - Common Stock net income for the last quarter?
Nephros, Inc. - Common Stock reported net income of 140 K for the last quarter. The previous quarter showed 62 K, which means net income changed by +125.81%.
How many employees does Nephros, Inc. - Common Stock have?
As of the latest available data, Nephros, Inc. - Common Stock has 36 employees. Workforce size can provide additional context about the company's scale and operations.
What is Nephros, Inc. - Common Stock EBITDA?
Nephros, Inc. - Common Stock EBITDA is 8.11 M, and its EBITDA margin is 155.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Nephros, Inc. - Common Stock stock?
You can buy Nephros, Inc. - Common Stock (NEPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Nephros, Inc. - Common Stock stock?
Investing in Nephros, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NEPH chart and related analysis on metatrader.com as part of your research.